Allergic asthma is a genetically complex disease characterized by allergen-specific immunoglobulin (Ig)E, eosinophilic inflammation of the lungs and airway hyper-responsiveness to bronchospasmogenic stimuli. In this study, we compared 13 recombinant congenic (RC) mouse strains in an ovalbumin model of allergic asthma. Different intensities and types of responses are observed throughout the RC strains. Intensities range from resistance to asthma in CcS05, to a very severe bronchoconstrictive reaction upon methacholine challenge for the parental STS strain. All strains show a 'modified' Th2 response except CcS14, which shows a 'true' Th2 response. When data from all strains are pooled, airway reactivity shows significant correlations with the serum Ig levels and the levels of interleukin (IL)-4, IL-5 and IL-13 in the broncho-alveolar lavage (BAL), at low dosage of methacholine (below 25 mg/ml), whereas at high dosage airway reactivity only correlates with BAL neutrophil levels. This indicates that at least two different mechanisms are involved in the airway reactivity to methacholine. None of these correlations can be found in every individual strain, which demonstrates that the asthma traits in this mouse model are genetically dissociated and that the loci can be genetically mapped.
Introduction
Allergic asthma is a heterogeneous disease, which can be characterized by allergen-specific immunoglobulin (Ig)E levels in serum, reversible airway obstruction, chronic eosinophilic inflammation of the airway tissue and hyper-responsiveness of the airways to nonspecific bronchospasmogenic stimuli. Genetic susceptibility to asthma appears to be due to multiple genes that interact with each other and the environment. Genome-wide screens for asthma and atopy have been performed in different ethnic populations and resulted in statistical evidence for linkage to several chromosomal regions including 5q, 11q and 12q. [1] [2] [3] [4] [5] [6] Some of these regions contain relevant candidate genes that may regulate IgE responses, Th-cell differentiation, inflammatory processes and airway hyper-responsiveness (AHR). Although an increasing number of linkages for atopic diseases have been confirmed, 7 it remains to be demonstrated that all candidate genes are linked to the pathophysiology of asthma.
Fine-mapping and identification of all the genes involved in asthma-related traits has proven to be extremely difficult not in the least part owing to epistatic interactions. Until now five potential susceptibilty genes for atopy or asthma were identified using positional approaches: a desintegrin and metalloproteinase 33 (ADAM33), [8] [9] [10] dipeptidyl peptidase 10, 11 plant homeodomain zinc-finger protein 11, 12 G-protein coupled receptor for asthma 13 and serine protease inhibitor Kazal type 5 (SPINK5). 14 
Polymorphisms of both ADAM33 and SPINK5
were not associated with asthma in some of the tested populations. 15, 16 This could be due to different phenotyping of asthma or epistatic interactions but it cannot be excluded that other polymorphisms in close linkage disequilibrium to the polymorphisms of both ADAM33 and SPINK5 are conferring the asthma susceptibility.
Although an animal model of asthma may not exhibit all aspects of the disease, identification of genes involved in certain well-defined characteristics may accelerate further human studies. Given the considerable homology between the human and mouse genome, the mouse has proven to be a useful genetic model for complex human diseases. 17, 18 Furthermore, genetic homogeneity and strictly controlled environmental conditions are major advantages of mouse models as well as the fact that the mouse 'toolbox' (gene-targeted mice, genetic and physical map) is very well developed.
Nowadays, a number of genetic tools are available for localization of genes involved in disease development. 18 In several diseases, the recombinant congenic (RC) strains of mice have proven to be a powerful tool to provide the mapping of genes controlling complex traits. 17, [19] [20] [21] [22] [23] [24] [25] [26] [27] A series of RC strains comprises approximately 20 homozygous strains, each of which contains on average 87.5% genes of a common background strain and 12.5% of a common donor strain. 26, 28 In this way, the RC system transforms a multigenic difference into a set of mono-or oligogenic differences and hence offers higher resolution power in mapping the quantitative trait loci and detecting their mutual interactions than the standard genetic methods. The RC system has been used most successfully to map genes in colon tumor susceptibility. [29] [30] [31] [32] One of the RC strains series, CcS/Dem, generated by Demant and colleagues uses BALB/cHeA as background strain and STS/A as donor strain. 33 The BALB/c mice produce high serum IgE levels whereas the STS/A shows low serum IgE levels after Leishmania major infection. 17 This series of RC strains has been used to dissect the genetics of T-cell activation and several models of inflammatory diseases, including Mycobacterium tuberculosis and L. major infection. 17, [19] [20] [21] [22] [23] [24] [25] 27 In the present study, we used the CcS/Dem series to determine the susceptibility of each strain and both parental strains BALB/cHeA and STS/A for antigeninduced airway manifestations of asthma as described by Deurloo et al. 34 Generated data were used to calculate correlations between the different asthma-related characteristics for all individual strains and in the pooled population.
Results

Airway reactivity
After ovalbumin (OVA) challenges, the parental STS strain shows a very severe bronchoconstrictive reaction at doses of methacholine above 12.5 mg/ml. Therefore, STS was not exposed to the complete dose-range, and Penh measurements obtained for STS were not used for further statistical analysis.
All tested strains show an increase in airway reactivity after OVA challenge compared to before challenge (data not shown), which is significant at high doses of methacholine (25 and 50 mg/ml) for all strains except CcS03 (only at 50 mg/ml), CcS05, 12, 13 and 15.
After challenge none of the tested strains, except STS, show a consistent and significant deviation in Penh compared to BALB/c at doses of methacholine below 25 mg/ml. At 25 and 50 mg/ml, however, significantly lower Penh values are seen in CcS02, 03, 05, 07, 11, 12, 13, 15 and 18. For CcS20, this difference is only significant at 25 mg/ml methacholine. Surprisingly, none of the tested RC strains show a significant higher extent of airway reactivity, compared to BALB/c, whereas the donor strain, STS, shows a much more severe bronchoconstrictive reaction compared to the background strain BALB/c (see Table 1a and b).
Serum Ig levels OVA-specific IgE levels are significantly increased after challenge compared to before challenge in BALB/c, CcS02, 07, 14 and 20. IgG1 and IgG2a levels after challenge are increased in all strains except CcS03 (only IgG2a is increased), 11, 13, 18 and STS (only IgG2a is increased), compared to before challenge.
After challenge, CcS01, 05, 07 and STS have significantly lower OVA-specific IgE levels compared to BALB/c, whereas significantly higher levels are measured in the serum of CcS11, 12 and 14. IgG1 levels after challenge are strongly and significantly lower in CcS05 and CcS13 compared to BALB/c after challenge. Only CcS05 mice show significant lower IgG2a levels compared to BALB/c (see Table 1a and b).
Cellular composition of the broncho-alveolar lavage fluid Owing to the severe bronchoconstriction in the STS mice, broncho-alveolar lavage (BAL) could not be performed reliably. Compared to BALB/c, total cell counts are higher in CcS01, CcS02 and CcS03, and significantly lower in all other strains except in CcS07, 14, 15 and 20. Despite this significant lower total cell count, the number of eosinophils is not significantly lower in CcS10, 11, 12 and 13 compared to BALB/c.
Cytokine composition of the BAL fluid
No interferon (IFN)-g could be detected in the BAL fluid of any of the tested strains (detection limit 160 pg/ml).
Compared to BALB/c, higher interleukin (IL)-4 levels are measured in the BAL fluid of CcS01, 07, 11, 12, 14 and 18. None of the tested strains show significantly lower IL-4 levels compared to BALB/c. IL-5 is higher in the BAL fluid of CcS14 and CcS18 and strongly lower in CcS05 compared to BALB/c. The anti-inflammatory cytokine IL-10 is significantly higher in CcS01, 07, 12, 14, 15 and 18. None of the tested strains show significantly lower IL-10 content of the BAL fluid, compared to BALB/c. IL-13 is significantly lower in CcS05 and significantly higher in CcS14 and 18.
Correlations between asthma-related parameters Remarkably, in the pooled population different correlations between airway reactivity (Penh) and other asthmarelated parameters are observed at high doses of methacholine (25 and 50 mg/ml) compared to low doses of methacholine (12.5 mg/ml and below). At low doses of methacholine, airway reactivity significantly correlates to serum IgE levels, BAL IL-4, -5 and -13 levels whereas at high doses of methacholine, airway reactivity correlates to neutrophil content of the BAL (at 25 and 50 mg/ ml). At 1 mg/ml methacholine, Penh also correlates with the eosinophil and IL-10 content of the BAL fluid (see Table 2 ). Airway reactivity correlates to both IgG1 and IgG2a (except at 3 mg/ml) at all doses of methacholine.
Strong significant correlations are seen between IgE, IgG1 and IgG2a levels. The IgE levels also correlate significantly with all measured Th2 cytokines and the eosinophil content of the BAL. IgG1 and IgG2a serum levels correlate with all cell types and the IL-4 and IL-5 content of the BAL. Additionally, IgG2a serum levels correlate with the IL-13 BAL levels.
Eosinophil, neutrophil, mononuclear and total cell content of the BAL fluid significantly correlate to each other. A significant correlation is also seen among all cell types and the IL-5, IL-10 and IL-13 levels (no significant correlation between IL-13 and neutrophils), but surprisingly not with IL-4.
Some of these correlations, which are observed in the pooled population, appear in some of the individual strains but none is observed in every single strain. Additionally, some strains show significant correlations, which are not detected in the pooled population (data not shown).
Discussion
In this study, we clearly demonstrate the influence of the genetic background on the susceptibility to experimental Table 1b Mean7s.e.m. for BALB/c and mean% of BALB/c7% standard error defined as ((mean for strain7s.e.m.)/mean for BALB/c) Â 100 
Penh (1.6 mg/ml) Antigen-induced airway manifestations of asthma B Piavaux et al asthma, as a broad range of susceptibilities is observed throughout the RC CcS/Dem strains. Ranging from a severe methacholine-induced bronchoconstriction in the parental STS strain to resistance observed in the CcS05 strain, which only showed limited airway reactivity at the highest dose of methacholine (50 mg/ml), low IgE, IgG1 and IgG2a levels and low levels of IL-5 and IL-10 in the BAL fluid. The group of Demant observed that CcS05 was also highly resistant to L. major infection, another Th2-related disease. 23 Interestingly, not only the susceptibility but also the type of response varies from one CcS/Dem strain to another. For example, mouse strain CcS14 shows a 'true' Th2 response upon OVA challenge, characterized by high IgE levels, low levels of IgG1 and IgG2a and high levels of Th2 cytokines. These high IgE and low IgG levels can be explained by an IL-4-mediated isotype switch, as high amounts of this cytokine can be found in the BAL fluid. Most other strains show a 'modified' Th2 response, characterized by lower IgE levels and a higher IgG1/IgE ratio. This 'modified' Th2 response has been previously described as a mechanism that induces less severe atopic or asthmatic responses, compared to 'true' Th2 response. 35 In our study, however, the 'true' Th2 responder, CcS14, does not show higher airway reactivity nor allergic inflammation, compared to BALB/c.
These differences in asthma-related phenotypes are in accordance with Whitehead et al., 36 who also showed the importance of genetic background on the development of allergen-induced airway diseases, using nine genetically diverse inbred mouse strains in an OVA model of asthma.
Several groups have shown that IL-13 is crucial for the development of asthmatic AHR. IL-13-KO mice, for example, show no AHR despite an extensive eosinophilic inflammation of the lungs. 37 The groups of Bleecker and Postma showed an association between a polymorphism in the IL-13 promoter and bronchial hyper-reactivity in a Dutch population of asthmatics. 38 Vladich et al. 39 recently demonstrated that the IL-13 2044GA polymorphism, which is associated with allergy and asthma, encodes for a form of IL-13, which is more active and less effectively neutralized. In our experiments, a significant correlation is seen between IL-13 and airway reactivity at low doses of methacholine (below 25 mg/ml), but not at high doses. Interestingly, CcS14 has highly increased and CcS10 highly decreased levels of all measured Th2 cytokines but no significant difference in airway reactivity is observed, compared to the parental strain BALB/c. This nicely illustrates the complexity of the development of AHR in our mouse model of asthma.
The group of Van Scott demonstrated the importance of IL-10 in the development of asthma using a ragweedsensitized and challenged C57/BL6 IL-10-KO mouse. These mice only developed AHR when recombinant IL-10 was administered together with the ragweed challenge, but not when IL-10 was given just before airway reactivity measurement using methacholine. 40 Also, the group of Gelfand used an IL-10-KO mouse, but in an OVA model of asthma. The mice only developed AHR when they were infected with a adenovirus encoding an IL-10 expression cassette before challenge. 41 Zhang et al. 42 found evidence for linkage between AHR and a locus on mouse chromosome 9, which among other genes also encodes the IL-10R. And more recently, Chatterjee Table 2 Spearman's rank correlation coefficients Antigen-induced airway manifestations of asthma B Piavaux et al et al. 43 found genetic association between asthma and a polymorphism in the IL-10 promoter sequence in human. In our experiments, IL-10 is only measured in the BAL at the end of the experiment. A correlation with airway reactivity is only seen at 1.6 mg/ml methacholine.
Also, IgE was investigated for its role in the development of AHR. Wynn et al. 44 suggest that the development of AHR is not dependent on the IgE production. This is supported by our results as the parental STS shows the lowest serum IgE levels but shows the strongest increase in Penh. On the other hand, CcS11 has significantly higher serum IgE levels, compared to BALB/c, but has significantly lower airway reactivity at methacholine doses of 12.5 mg/ml and above. Despite these observations, a significant correlation between airway reactivity and IgE levels is observed in our data at low methacholine doses, below 25 mg/ml, but not at higher doses.
These correlations may not reflect causal relationship but they nicely fit in a model in which the response to methacholine is caused by at least two mechanisms. The first one is predominant at low doses of methacholine (below 25 mg/ml) and is related to the Th2-mediated inflammatory state of the lungs and by this correlates to the cytokine and Ig levels and eosinophil count.
The second mechanism becomes predominant at high doses of methacholine and is related to the neutrophil content of the BAL. This second mechanism gives rise to much higher airway responses, compared to the first one, and could therefore, be considered as the main mechanism involved in AHR in this mouse model of allergic asthma.
Interestingly, none of the correlations described above can be found in every individual strain. This confirms the complex multigenic character of asthma features and highlights the suitability of the CcS/Dem strains to map the genes involved. It also highlights the fact that none of the tested phenotypes are directly linked and that other factors play a role in the development of an asthmatic response in this mouse model. RC strains are a powerful tool to unravel the genetics of genetically complex processes as it allows mapping of the genes involved. For example, Nicolaides et al. 45 could identify IL-9 as a quantitative trait locus implicated in the normal airway response to acetylcholine. Also, the CcS/ Dem strains, which were also used in our experiments, have already been successfully used by different groups. Lipoldova et al. for example were able to identify five novel L. major resistance loci using CcS05 17 and Havelkova et al. 46 used CcS09 and CcS11 for the identification of genes involved in T-cell-receptor-induced activation.
It can be concluded that the RC system is a useful tool to map and identify asthma-related genes, as the same correlations between asthma-related characteristics are found in human and mouse model and a broad range of intensity and type of 'asthmatic' responses are observed. Moreover, the different asthma characteristics segregate independently, which makes it possible to map loci implicated in these different characteristics.
Additionally, it can be hypothesized that at least two mechanisms are involved in the airway reactivity to methacholine in our mouse model of asthma, a first one, predominant at low doses of methacholine, is related to the allergic inflammatory state of the lungs, whereas the second one is related to BAL neutrophils and is predominant at high doses of methacholine.
Materials and methods
Mice
Male, 5-9 week-old BALB/cHeA, STS/A and CcS/ Dem 22 mice were obtained from the breeding colony of P Demant. Seven to eleven mice per strain were phenotyped (see Table 1a and b). Animal care and use were performed in accordance with the guidelines of the Dutch Committee of Animal experiments. The mice were kept under specified pathogen-free conditions according to the guidelines of the Federation of European Laboratory Animal Science Association. 47 They were housed in enriched macrolon cages under filter top or in a laminar flow cabinet with food and water administered ad libitum.
Experimental asthma protocol On days 0 and 7, the animals were intraperitoneally sensitized with 10 mg OVA in 2 mg Alum adjuvant (Pierce, Rockfort, IL, USA). One week after the second sensitization blood was taken. Subsequently, the animals were challenged for 20 min with 10 mg OVA/ml in saline, starting on day 21 and then once per 3 days for a total of three times. Twenty-four hours after the last challenge, airway responsiveness to methacholine was measured. Consecutively, blood and BAL fluid were collected.
Airway responsiveness
Airway responsiveness was measured in conscious, unrestrained mice before (day 18) and after (day 28) OVA challenges. Airway reactivity was determined by recording respiratory pressure curves in response to inhaled nebulized methacholine (acetyl-b-methylcholine chloride; Sigma, St Louis, MO, USA) at doses of 1.6, 3.1, 6.3, 12.5, 25 and 50 mg/ml using barometric whole-body plethysmography (BUXCO, Wilmington, NC, USA). Airway responses were expressed in enhanced pause (Penh), an index of airway obstruction as described in detail previously. 48 STS mice were not exposed to doses above 12.5 mg/ml methacholine as higher doses induce a very severe bronchoconstrictive reaction.
OVA-specific Ig levels in serum After measurement of in vivo airway reactivity, mice were killed by intraperitoneal injection of 1 ml 10% urethane in pyrogen-free saline (Sigma, St Louis, MO, USA). Subsequently, mice were bled by cardiac puncture and serum was collected and stored at À701C until analysis. Levels of OVA-specific IgE, IgG1 and IgG2a in the serum were measured as described previously. 49 A reference standard was used with arbitrary units of each isotype of 1000 EU/ml. The detection levels of the enzyme-linked immunosorbent assays (ELISAs) were 0.05 EU/ml for IgG2a, 0.5 EU/ml for IgE and 0.005 EU/ ml for IgG1.
Analysis of the cellular composition in the BAL fluid Immediately after bleeding, the lungs were lavaged through a tracheal cannula with 1 ml saline at 371C containing 5% BSA and 2 mg/ml aprotinine (Roche Diagnostics, Basel, Switzerland). Cells were spun down and supernatant was stored at À201C until measurement of cytokines was carried out by ELISA. Subsequently, lungs were lavaged four times with 1 ml aliquots of saline. The BAL cells were washed with PBS (400 g, 41C, 5 min) and the pellet was resuspended in 150 ml PBS. Total numbers of BAL cells were counted in a Burker-Tü rk chamber (Omnilabo, Breda, The Netherlands). For differential BAL cell counts, cytospin preparations were stained with Diff-Quick (Merz & Dade A.G., Dudingen, Switzerland). After they were coded, all cytospin preparations were evaluated by one observer. Cells were identified and differentiated into mononuclear cells, lymphocytes, neutrophils and eosinophils by standard morphology. At least 200 cells were counted per cytospin preparation.
Cytokine ELISAs
Cell-free supernatants of the first milliliter of BAL fluid were analyzed for IL-4, IL-5, IL-10, IL-13 and IFN-g content by sandwich ELISA using antibody pairs and standards purchased from PharMingen, according to the manufacturer's instructions. The lower detection limits of the ELISAs were 16 pg/ml for IL-4, 32 pg/ml for IL-5, 100 pg/ml for IL-10 and IL-13 and 160 pg/ml for IFN-g.
Statistical analysis
Results obtained before and after OVA challenge were compared using signed-rank tests. The different strains were compared to BALB/c using Mann-Whitney U-test. Correlations were calculated using Spearman's rank correlations. False discovery rate for correlation tests was estimated to be 5% for the 95 and 1% for the 99% confidence intervals by computing correlations in 1000 permuted data sets. Statistical analyses were performed using SAS for Windows version 9.0 (SAS-Institute, Cary, NC, USA).
